By www.reliablemarketsize.com
Global Gene Therapy For CNS Disorders Market Size, Status And Forecast 2024-2031 Story
100
$ 3900
Gene Therapy For CNS Disorders Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Gilead (Kite Pharma) Amgen (BioVex) Novartis Roche (Spark Therapeutics) Bluebird Bio